We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+6.21%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$907M
AUM Growth
+$198M
Cap. Flow
+$174M
Cap. Flow %
19.24%
Top 10 Hldgs %
37.32%
Holding
434
New
22
Increased
336
Reduced
40
Closed
7

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$24.7M
2
MSFT icon
Microsoft
MSFT
+$10.9M
3
AMGN icon
Amgen
AMGN
+$7.39M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7M
5
NVDA icon
NVIDIA
NVDA
+$6.68M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$6.5M
2
NOW icon
ServiceNow
NOW
+$4.69M
3
CRM icon
Salesforce
CRM
+$4.67M
4
CRWD icon
CrowdStrike
CRWD
+$4.38M
5
QCOM icon
Qualcomm
QCOM
+$3.51M

Sector Composition

Rank Sector Weight
1 Technology 37.6%
2 Healthcare 28.11%
3 Consumer Discretionary 12.57%
4 Communication Services 9.53%
5 Consumer Staples 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXRX icon
351
Lexicon Pharmaceuticals
LXRX
$1.05B
$109K 0.01%
69,527
+27,058
+64% +$48.2K
FDMT icon
352
4D Molecular Therapeutics
FDMT
$621M
$108K 0.01%
9,995
+3,922
+65% +$65.1K
THRD
353
DELISTED
Third Harmonic Bio
THRD
$107K 0.01%
7,904
+3,092
+64% +$38.3K
RVNC
354
DELISTED
Revance Therapeutics, Inc.
RVNC
$105K 0.01%
20,161
+7,890
+64% +$39.2K
URGN icon
355
UroGen Pharma
URGN
$2.39B
$103K 0.01%
8,100
+3,856
+91% +$57.2K
RGNX icon
356
Regenxbio
RGNX
$720M
$99.7K 0.01%
9,506
+3,720
+64% +$45.3K
OABI icon
357
OmniAb
OABI
$497M
$96.1K 0.01%
22,727
+8,909
+64% +$38.5K
KALV
358
DELISTED
KalVista Pharmaceuticals
KALV
$96K 0.01%
8,286
+3,328
+67% +$41.9K
SLRN
359
DELISTED
ACELYRIN
SLRN
$94.6K 0.01%
19,196
+7,560
+65% +$39K
SIGA icon
360
SIGA Technologies
SIGA
$206M
$92.7K 0.01%
13,727
+5,372
+64% +$46.9K
AVXL icon
361
Anavex Life Sciences
AVXL
$316M
$92.6K 0.01%
16,309
+6,366
+64% +$36.7K
PACB icon
362
Pacific Biosciences
PACB
$345M
$92.4K 0.01%
54,335
+20,417
+60% +$33.5K
PRME icon
363
Prime Medicine
PRME
$580M
$89.3K 0.01%
23,086
+8,985
+64% +$41.6K
PAHC icon
364
Phibro Animal Health
PAHC
$1.37B
$88.1K 0.01%
3,912
+1,522
+64% +$29.4K
ALEC icon
365
Alector
ALEC
$240M
$87.2K 0.01%
18,718
+7,395
+65% +$39.7K
SAGE
366
DELISTED
Sage Therapeutics
SAGE
$84.8K 0.01%
11,742
+4,672
+66% +$42.8K
EYPT icon
367
EyePoint Inc
EYPT
$1.17B
$82.2K 0.01%
10,293
+4,172
+68% +$36.6K
GRAL
368
GRAIL Inc
GRAL
$3.08B
$82.2K 0.01%
5,972
+2,670
+81% +$40.5K
XERS icon
369
Xeris Biopharma Holdings
XERS
$1.55B
$81.7K 0.01%
28,657
+11,239
+65% +$28.9K
TSHA icon
370
Taysha Gene Therapies
TSHA
$2.05B
$79.2K 0.01%
39,417
+17,446
+79% +$38.3K
VERV
371
DELISTED
Verve Therapeutics
VERV
$78.8K 0.01%
16,276
+6,412
+65% +$37.2K
MXCT icon
372
MaxCyte
MXCT
$136M
$78.6K 0.01%
20,212
+7,930
+65% +$33.4K
TBPH icon
373
Theravance Biopharma
TBPH
$878M
$75.8K 0.01%
9,409
+3,696
+65% +$32K
ACIU icon
374
AC Immune
ACIU
$267M
$71.9K 0.01%
19,021
+7,400
+64% +$25.8K
ITOS
375
DELISTED
iTeos Therapeutics
ITOS
$71.7K 0.01%
7,024
+2,646
+60% +$40.4K
13 14
15
16 17

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q3 2024 Portfolio in Review

As of Q3 2024, China Universal Asset Management Company held 434 positions worth $907M, up 28% from $709M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

China Universal Asset Management Company deployed $174M of net new capital in Q3 2024, opening 22 new positions and adding to 336 existing holdings. Its largest new stake was SAP: 16,500 shares worth $3.78M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 44% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Micron Technology, an estimated $6.5M trimmed.

  • China Universal Asset Management Company's largest Q3 2024 buy was SAP: 16,500 shares worth $3.78M.
  • China Universal Asset Management Company added most to Apple in Q3 2024, an estimated $24.7M increase.
  • China Universal Asset Management Company's biggest Q3 2024 reduction was Micron Technology, cutting an estimated $6.5M.
  • China Universal Asset Management Company fully exited Tencent Music in Q3 2024, selling an estimated $2.89M.
  • China Universal Asset Management Company's ten largest holdings make up 37% of its $907M portfolio in Q3 2024.
  • China Universal Asset Management Company opened 22 new positions and closed 7 in Q3 2024.
  • China Universal Asset Management Company's portfolio value rose 28% quarter-over-quarter to $907M.

Based on China Universal Asset Management Company's 13F filing for Q3 2024, filed 25 Oct 2024.